A szkizofrénia és a genetikai hajlam

Mit tudunk, és mit hoz a jövo{double acute}?

Translated title of the contribution: Genetic predisposition to schizophrenia: What did we learn and what does the future hold?

Andrea Vereczkei, Karoly Mirnics

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Schizophrenia is a complex, devastating brain disorder with clear genetic and environmental contributions to the emergence of the disease. In the last several decades of research hundreds of millions of dollars were spent of the elusive search for schizophrenia susceptibility genes, but the results have been meager. Researchers have identified a number of genetic variants that predispose the brain to developing the disease, yet alone they can explain only a very small number of the schizophrenia occurrence. Vulnerability in DISC1, NRG1, DTNBP1, RGS4, KCNH2, COMT,'licated across multiple cohorts and do not lead to altered protein structure. In summary, we argue that large-scale genetic studies will not provide us with the answers we seek: we have to accept that there are no schizophrenia-predisposing genes with large effect sizes, and due to the diversity of findings, genetics-based novel therapies of schizophrenia are not realistic. The new treatments will have to come from functional studies of intracellular pathways and understanding the confluence of environmental influences and genetic predisposition, and their combined effects on developmental mechanisms and intracellular cascades.

Original languageHungarian
Pages (from-to)205-210
Number of pages6
JournalNeuropsychopharmacologia Hungarica
Volume13
Issue number4
DOIs
StatePublished - Dec 1 2011

Fingerprint

Genetic Predisposition to Disease
Schizophrenia
Brain Diseases
Genes
Research Personnel
Brain
Research
Proteins
Therapeutics

Keywords

  • Copy number variation
  • Genetic predisposition
  • Genome-wide association studies
  • Schizophrenia
  • Susceptibility genes

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Clinical Neurology

Cite this

A szkizofrénia és a genetikai hajlam : Mit tudunk, és mit hoz a jövo{double acute}? / Vereczkei, Andrea; Mirnics, Karoly.

In: Neuropsychopharmacologia Hungarica, Vol. 13, No. 4, 01.12.2011, p. 205-210.

Research output: Contribution to journalReview article

@article{d329d9c00fb54f318ade939c9dd6ae29,
title = "A szkizofr{\'e}nia {\'e}s a genetikai hajlam: Mit tudunk, {\'e}s mit hoz a j{\"o}vo{double acute}?",
abstract = "Schizophrenia is a complex, devastating brain disorder with clear genetic and environmental contributions to the emergence of the disease. In the last several decades of research hundreds of millions of dollars were spent of the elusive search for schizophrenia susceptibility genes, but the results have been meager. Researchers have identified a number of genetic variants that predispose the brain to developing the disease, yet alone they can explain only a very small number of the schizophrenia occurrence. Vulnerability in DISC1, NRG1, DTNBP1, RGS4, KCNH2, COMT,'licated across multiple cohorts and do not lead to altered protein structure. In summary, we argue that large-scale genetic studies will not provide us with the answers we seek: we have to accept that there are no schizophrenia-predisposing genes with large effect sizes, and due to the diversity of findings, genetics-based novel therapies of schizophrenia are not realistic. The new treatments will have to come from functional studies of intracellular pathways and understanding the confluence of environmental influences and genetic predisposition, and their combined effects on developmental mechanisms and intracellular cascades.",
keywords = "Copy number variation, Genetic predisposition, Genome-wide association studies, Schizophrenia, Susceptibility genes",
author = "Andrea Vereczkei and Karoly Mirnics",
year = "2011",
month = "12",
day = "1",
doi = "10.5706/nph201112003",
language = "Hungarian",
volume = "13",
pages = "205--210",
journal = "Neuropsychopharmacologia Hungarica",
issn = "1419-8711",
publisher = "Hungarian Association of Psychopharmacology",
number = "4",

}

TY - JOUR

T1 - A szkizofrénia és a genetikai hajlam

T2 - Mit tudunk, és mit hoz a jövo{double acute}?

AU - Vereczkei, Andrea

AU - Mirnics, Karoly

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Schizophrenia is a complex, devastating brain disorder with clear genetic and environmental contributions to the emergence of the disease. In the last several decades of research hundreds of millions of dollars were spent of the elusive search for schizophrenia susceptibility genes, but the results have been meager. Researchers have identified a number of genetic variants that predispose the brain to developing the disease, yet alone they can explain only a very small number of the schizophrenia occurrence. Vulnerability in DISC1, NRG1, DTNBP1, RGS4, KCNH2, COMT,'licated across multiple cohorts and do not lead to altered protein structure. In summary, we argue that large-scale genetic studies will not provide us with the answers we seek: we have to accept that there are no schizophrenia-predisposing genes with large effect sizes, and due to the diversity of findings, genetics-based novel therapies of schizophrenia are not realistic. The new treatments will have to come from functional studies of intracellular pathways and understanding the confluence of environmental influences and genetic predisposition, and their combined effects on developmental mechanisms and intracellular cascades.

AB - Schizophrenia is a complex, devastating brain disorder with clear genetic and environmental contributions to the emergence of the disease. In the last several decades of research hundreds of millions of dollars were spent of the elusive search for schizophrenia susceptibility genes, but the results have been meager. Researchers have identified a number of genetic variants that predispose the brain to developing the disease, yet alone they can explain only a very small number of the schizophrenia occurrence. Vulnerability in DISC1, NRG1, DTNBP1, RGS4, KCNH2, COMT,'licated across multiple cohorts and do not lead to altered protein structure. In summary, we argue that large-scale genetic studies will not provide us with the answers we seek: we have to accept that there are no schizophrenia-predisposing genes with large effect sizes, and due to the diversity of findings, genetics-based novel therapies of schizophrenia are not realistic. The new treatments will have to come from functional studies of intracellular pathways and understanding the confluence of environmental influences and genetic predisposition, and their combined effects on developmental mechanisms and intracellular cascades.

KW - Copy number variation

KW - Genetic predisposition

KW - Genome-wide association studies

KW - Schizophrenia

KW - Susceptibility genes

UR - http://www.scopus.com/inward/record.url?scp=84858237854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858237854&partnerID=8YFLogxK

U2 - 10.5706/nph201112003

DO - 10.5706/nph201112003

M3 - Review article

VL - 13

SP - 205

EP - 210

JO - Neuropsychopharmacologia Hungarica

JF - Neuropsychopharmacologia Hungarica

SN - 1419-8711

IS - 4

ER -